Covid 19 Research using Clinical Trials (Home Page)
HP:0100658: CellulitisHPO
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug841 | Data collection and rhinopharyngeal swab Wiki | 1.00 |
Correlated MeSH Terms (3)
| Name (Synonyms) | Correlation | |
|---|---|---|
| D009877 | Endophthalmitis NIH | 1.00 |
| D002481 | Cellulitis NIH | 1.00 |
| D054517 | Orbital Cellulitis NIH | 1.00 |
Correlated HPO Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
To report on cases presented with combined endophthalmitis and orbital cellulitis as a first presentation of covid-19 infection.
NCT04456556 Endophthalmitis and Orbital Cellulitis MeSH:Cellulitis Endophthalmitis Orbital Cellulitis
HPO:Cellulitis
Primary Outcomes
Description: highlight the occurrence of combined endophthalmitis and orbital cellulitis in patients with novel Coronavirus Disease (COVID-19)
Measure: Combined Endophthalmitis and Orbital Cellulitis in patients with Novel Coronavirus Disease (COVID-19) Time: baseline
HPO Nodes
Primary Outcomes
Description: highlight the occurrence of combined endophthalmitis and orbital cellulitis in patients with novel Coronavirus Disease (COVID-19)
Measure: Combined Endophthalmitis and Orbital Cellulitis in patients with Novel Coronavirus Disease (COVID-19) Time: baseline